Li-Fraumeni syndrome in the setting of re-occurring malignancies after 27 years of remission: a case report

Author:

Mousa Ahmed H.1,Ibrahim Abdullatif S.1,Alsayed Abdelrahman Waleed1,Albukhari Zain Z.1,Mogharbel Ajfan2,Alshanberi Asim M.13,Albar Nezar Y.4

Affiliation:

1. College of Medicine and Surgery, Batterjee Medical College, Jeddah, Saudi Arabia

2. Ibn Siena National College, Medicine and Surgery

3. Department of Community Medicine and Pilgrims Health Care, Umm Al-Qura University, Makkah

4. Dr. Samir Abbas Hospital, Jeddah, Saudi Arabia

Abstract

Introduction and importance: Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. Case presentation: Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. Clinical discussion: The surgical cytoreduction or ‘debulking’ technique is the main treatment option started in individuals with High Grade Serous Ovarian CanceR. This surgical strategy aims to completely remove all disseminated tumor masses that are present in the patient’s peritoneal cavity on a macroscopic level. Conclusion: In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago. Multiple primary tumors are defined as multiple simultaneous (within 6 months) or heterogeneous tumors. Here, the authors present the case of a 58-year-old Saudi female patient with Li-Fraumeni syndrome who has multiple primary tumors. In conclusion, in our case, she has developed her ovarian cancer 27 years after her breast cancer got treated. This was already stage IIIB to stage IV. If it was not for her incidental discovery of her urinary bladder cancer, which is most likely is a long-term sequel of using cyclophosphamide 27 years ago.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference14 articles.

1. Multiple primary tumours: challenges and approaches, a review;Vogt;ESMO Open,2017

2. Multiple primary tumors: a case report and review of the literature;Zhao;BMC Musculoskeletal Disorders,2020

3. Beyond Li-Fraumeni syndrome: clinical characteristics of families with p53 germline mutations;Gonzalez;J Clin Oncol,2008

4. Bressac-de Paillerets B, Berthet P, Dugast C, Bonaïti-Pellié C. 2009 version of the Chompret criteria for Li Fraumeni syndrome;Tinat;J Clin Oncol,2009

5. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers;Nichols;Cancer Epidemiol Biomarkers Prev,2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3